Xiaoxue Li

Statistics

Publications

Citations

104

H-Index

Active since

2010

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

Xiaoxue Li is an author at Center for Drug Evaluation and Research specializing in volumetric imaging, quadratic optimization, and quadratic programming relaxations.

ORCID

Publications per year

2010–2025

Publications

FDA Approval Summary: Alpelisib for PIK3CA-Related Overgrowth Spectrum

Sonia Singh, Diana Bradford, Xiaoxue Li et al. · Clinical Cancer Research · 2023 · 44 citations · Full text

Medicine, Pediatrics, Radiology +13

A new relaxation framework for quadratic assignment problems based on matrix splitting

Jiming Peng, Hans D. Mittelmann, Xiaoxue Li · Mathematical Programming Computation · 2010 · 33 citations

Natural Sciences, Computer Science, Algorithms +10

FDA Approval Summary: Tovorafenib for Relapsed or Refractory BRAF-Altered Pediatric Low-Grade Glioma

Sonia Singh, Diana Bradford, Somak Chatterjee et al. · Clinical Cancer Research · 2025 · 17 citations · Full text

Medicine, Oncology, Pharmacology +15

FDA Approval Summary: Vorasidenib for <i>IDH</i> -Mutant Grade 2 Astrocytoma or Oligodendroglioma Following Surgery

Michael I. Barbato, Amy Barone, Stephanie Aungst et al. · Clinical Cancer Research · 2025 · 10 citations · Full text

Medicine, Neurological Surgery, Oncology +17

1–4 of 4